Peptidases modulate bradykinin-induced arteriolar dilation in the hamster cheek pouch

X. P. Gao, P. Anding, R. A. Robbins, S. I. Rennard, I. Rubinstein

Research output: Contribution to journalArticle

19 Citations (Scopus)

Abstract

The purpose of this study was to investigate whether angiotensin- converting enzyme (ACE; EC 3.4.15.1) and neutral endopeptidase (NEP; EC 3.4.24.11), two membrane-bound metalloenzymes that are widely distributed in the peripheral microcirculation and degrade kinins very effectively, modulate bradykinin-induced arteriolar dilation in vivo. Using intravital microscopy, we measured diameter of second-order arterioles in the hamster cheek pouch during suffusion of bradykinin (0.1-10.0 μM) before and after topical application of captopril (10.0 μM) and phosphoramidon (10.0 nM). We found that each inhibitor significantly potentiated bradykinin-induced increase in arteriolar diameter (P < 0.05). Suffusion of other proteinase inhibitors (excluding ACE and NEP inhibitors) had no significant effect on bradykinin- induced responses. Captopril and phosphoramidon did not potentiate isoproterenol (0.1 μM)-induced arteriolar dilation in the cheek pouch. Collectively, these data indicate that ACE and NEP each plays an important role in regulating bradykinin-induced vasorelaxation in the peripheral microcirculation in vivo.

Original languageEnglish (US)
Pages (from-to)H93-H98
JournalAmerican Journal of Physiology - Heart and Circulatory Physiology
Volume266
Issue number1 35-1
StatePublished - Jan 1 1994

Fingerprint

bradykinin
Cheek
peptidases
Bradykinin
pouches
hamsters
Cricetinae
Dilatation
Peptide Hydrolases
Captopril
peptidyl-dipeptidase A
Microcirculation
kinins
Neprilysin
Kinins
vasodilation
topical application
Arterioles
Peptidyl-Dipeptidase A
proteinase inhibitors

Keywords

  • angiotensin-converting enzyme
  • endothelium
  • isoproterenol
  • microcirculation
  • neutral endopeptidase
  • proteinase inhibitors
  • proteinases

ASJC Scopus subject areas

  • Physiology
  • Cardiology and Cardiovascular Medicine
  • Physiology (medical)

Cite this

Gao, X. P., Anding, P., Robbins, R. A., Rennard, S. I., & Rubinstein, I. (1994). Peptidases modulate bradykinin-induced arteriolar dilation in the hamster cheek pouch. American Journal of Physiology - Heart and Circulatory Physiology, 266(1 35-1), H93-H98.

Peptidases modulate bradykinin-induced arteriolar dilation in the hamster cheek pouch. / Gao, X. P.; Anding, P.; Robbins, R. A.; Rennard, S. I.; Rubinstein, I.

In: American Journal of Physiology - Heart and Circulatory Physiology, Vol. 266, No. 1 35-1, 01.01.1994, p. H93-H98.

Research output: Contribution to journalArticle

Gao, XP, Anding, P, Robbins, RA, Rennard, SI & Rubinstein, I 1994, 'Peptidases modulate bradykinin-induced arteriolar dilation in the hamster cheek pouch', American Journal of Physiology - Heart and Circulatory Physiology, vol. 266, no. 1 35-1, pp. H93-H98.
Gao, X. P. ; Anding, P. ; Robbins, R. A. ; Rennard, S. I. ; Rubinstein, I. / Peptidases modulate bradykinin-induced arteriolar dilation in the hamster cheek pouch. In: American Journal of Physiology - Heart and Circulatory Physiology. 1994 ; Vol. 266, No. 1 35-1. pp. H93-H98.
@article{714d7e5357c249a291f16666dfa0c179,
title = "Peptidases modulate bradykinin-induced arteriolar dilation in the hamster cheek pouch",
abstract = "The purpose of this study was to investigate whether angiotensin- converting enzyme (ACE; EC 3.4.15.1) and neutral endopeptidase (NEP; EC 3.4.24.11), two membrane-bound metalloenzymes that are widely distributed in the peripheral microcirculation and degrade kinins very effectively, modulate bradykinin-induced arteriolar dilation in vivo. Using intravital microscopy, we measured diameter of second-order arterioles in the hamster cheek pouch during suffusion of bradykinin (0.1-10.0 μM) before and after topical application of captopril (10.0 μM) and phosphoramidon (10.0 nM). We found that each inhibitor significantly potentiated bradykinin-induced increase in arteriolar diameter (P < 0.05). Suffusion of other proteinase inhibitors (excluding ACE and NEP inhibitors) had no significant effect on bradykinin- induced responses. Captopril and phosphoramidon did not potentiate isoproterenol (0.1 μM)-induced arteriolar dilation in the cheek pouch. Collectively, these data indicate that ACE and NEP each plays an important role in regulating bradykinin-induced vasorelaxation in the peripheral microcirculation in vivo.",
keywords = "angiotensin-converting enzyme, endothelium, isoproterenol, microcirculation, neutral endopeptidase, proteinase inhibitors, proteinases",
author = "Gao, {X. P.} and P. Anding and Robbins, {R. A.} and Rennard, {S. I.} and I. Rubinstein",
year = "1994",
month = "1",
day = "1",
language = "English (US)",
volume = "266",
pages = "H93--H98",
journal = "American Journal of Physiology - Renal Physiology",
issn = "0363-6127",
publisher = "American Physiological Society",
number = "1 35-1",

}

TY - JOUR

T1 - Peptidases modulate bradykinin-induced arteriolar dilation in the hamster cheek pouch

AU - Gao, X. P.

AU - Anding, P.

AU - Robbins, R. A.

AU - Rennard, S. I.

AU - Rubinstein, I.

PY - 1994/1/1

Y1 - 1994/1/1

N2 - The purpose of this study was to investigate whether angiotensin- converting enzyme (ACE; EC 3.4.15.1) and neutral endopeptidase (NEP; EC 3.4.24.11), two membrane-bound metalloenzymes that are widely distributed in the peripheral microcirculation and degrade kinins very effectively, modulate bradykinin-induced arteriolar dilation in vivo. Using intravital microscopy, we measured diameter of second-order arterioles in the hamster cheek pouch during suffusion of bradykinin (0.1-10.0 μM) before and after topical application of captopril (10.0 μM) and phosphoramidon (10.0 nM). We found that each inhibitor significantly potentiated bradykinin-induced increase in arteriolar diameter (P < 0.05). Suffusion of other proteinase inhibitors (excluding ACE and NEP inhibitors) had no significant effect on bradykinin- induced responses. Captopril and phosphoramidon did not potentiate isoproterenol (0.1 μM)-induced arteriolar dilation in the cheek pouch. Collectively, these data indicate that ACE and NEP each plays an important role in regulating bradykinin-induced vasorelaxation in the peripheral microcirculation in vivo.

AB - The purpose of this study was to investigate whether angiotensin- converting enzyme (ACE; EC 3.4.15.1) and neutral endopeptidase (NEP; EC 3.4.24.11), two membrane-bound metalloenzymes that are widely distributed in the peripheral microcirculation and degrade kinins very effectively, modulate bradykinin-induced arteriolar dilation in vivo. Using intravital microscopy, we measured diameter of second-order arterioles in the hamster cheek pouch during suffusion of bradykinin (0.1-10.0 μM) before and after topical application of captopril (10.0 μM) and phosphoramidon (10.0 nM). We found that each inhibitor significantly potentiated bradykinin-induced increase in arteriolar diameter (P < 0.05). Suffusion of other proteinase inhibitors (excluding ACE and NEP inhibitors) had no significant effect on bradykinin- induced responses. Captopril and phosphoramidon did not potentiate isoproterenol (0.1 μM)-induced arteriolar dilation in the cheek pouch. Collectively, these data indicate that ACE and NEP each plays an important role in regulating bradykinin-induced vasorelaxation in the peripheral microcirculation in vivo.

KW - angiotensin-converting enzyme

KW - endothelium

KW - isoproterenol

KW - microcirculation

KW - neutral endopeptidase

KW - proteinase inhibitors

KW - proteinases

UR - http://www.scopus.com/inward/record.url?scp=0028045532&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0028045532&partnerID=8YFLogxK

M3 - Article

C2 - 8304527

AN - SCOPUS:0028045532

VL - 266

SP - H93-H98

JO - American Journal of Physiology - Renal Physiology

JF - American Journal of Physiology - Renal Physiology

SN - 0363-6127

IS - 1 35-1

ER -